Matt’s Promise is dedicated to making a difference in the lives of young people affected by terminal illnesses. Our commitment, through select funding of treatment, research, education, and support programs, is to advance the fight against these diseases and to assure the most comprehensive, innovative, and compassionate care.
BREAKING NEWS:
Results from current DMD Research: Successful phase one study C-1100 leads now to clinical trial for kids with DMD Sarepta's Exon Skipping Drug "looks like it is on to something big..."